Salivary gland cancer
The names of the lead clinicians for the IRCI Salivary gland cancer group include:
Dr Dr Robert Metcalf (UK)
Dr Alan Ho (US)
Dr Lisa Licitra (EORTC)
Current active trial
EORTC1206-HNCG – A randomised phase II study to evaluate the efficacy and safety of chemotherapy vs androgen deprivation therapy in patients with recurrent and/or metastatic, androgen receptor expressing, salivary gland cancer – an International Rare Cancers Initiative Study – IRCI 007
